2-47839485-T-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The ENST00000403359.8(FBXO11):c.376A>T(p.Thr126Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,613,956 control chromosomes in the GnomAD database, including 281 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T126A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000403359.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO11 | NM_001190274.2 | c.376A>T | p.Thr126Ser | missense_variant | 3/23 | ENST00000403359.8 | NP_001177203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO11 | ENST00000403359.8 | c.376A>T | p.Thr126Ser | missense_variant | 3/23 | 1 | NM_001190274.2 | ENSP00000384823.4 |
Frequencies
GnomAD3 genomes AF: 0.0225 AC: 3431AN: 152202Hom.: 143 Cov.: 32
GnomAD3 exomes AF: 0.00554 AC: 1389AN: 250696Hom.: 58 AF XY: 0.00400 AC XY: 542AN XY: 135606
GnomAD4 exome AF: 0.00229 AC: 3344AN: 1461636Hom.: 137 Cov.: 31 AF XY: 0.00189 AC XY: 1373AN XY: 727070
GnomAD4 genome AF: 0.0226 AC: 3440AN: 152320Hom.: 144 Cov.: 32 AF XY: 0.0218 AC XY: 1621AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
FBXO11-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 28, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at